IT1206513B - Composizioni farmaceutiche adattivita'antibiotica-immunostimolante. - Google Patents

Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.

Info

Publication number
IT1206513B
IT1206513B IT8322427A IT2242783A IT1206513B IT 1206513 B IT1206513 B IT 1206513B IT 8322427 A IT8322427 A IT 8322427A IT 2242783 A IT2242783 A IT 2242783A IT 1206513 B IT1206513 B IT 1206513B
Authority
IT
Italy
Prior art keywords
adaptity
immunostimulant
antibiotic
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
IT8322427A
Other languages
English (en)
Other versions
IT8322427A0 (it
Inventor
Fulvio Anzani
Renzo Viscardi
Franco Pivoli
Original Assignee
Btb Ind Chimica
Fraschini Franco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btb Ind Chimica, Fraschini Franco filed Critical Btb Ind Chimica
Priority to IT8322427A priority Critical patent/IT1206513B/it
Publication of IT8322427A0 publication Critical patent/IT8322427A0/it
Priority to DE198484108867T priority patent/DE139891T1/de
Priority to EP84108867A priority patent/EP0139891A3/en
Priority to AU31431/84A priority patent/AU3143184A/en
Priority to ZA845997A priority patent/ZA845997B/xx
Priority to JP59164179A priority patent/JPS6075431A/ja
Priority to IL72581A priority patent/IL72581A0/xx
Priority to ES534860A priority patent/ES534860A0/es
Application granted granted Critical
Publication of IT1206513B publication Critical patent/IT1206513B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IT8322427A 1983-08-04 1983-08-04 Composizioni farmaceutiche adattivita'antibiotica-immunostimolante. IT1206513B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT8322427A IT1206513B (it) 1983-08-04 1983-08-04 Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
DE198484108867T DE139891T1 (de) 1983-08-04 1984-07-26 Pharmazeutische zusammensetzungen mit antibiotisch-immunostimulativer wirkung.
EP84108867A EP0139891A3 (en) 1983-08-04 1984-07-26 Pharmaceutical compositions with antibiotic-immunostimulating activity
AU31431/84A AU3143184A (en) 1983-08-04 1984-08-02 Salts of erythromycin derivs with acid derivs of inosine
ZA845997A ZA845997B (en) 1983-08-04 1984-08-02 Pharmaceutical compositions with antibiotic-immunostimulating activity
JP59164179A JPS6075431A (ja) 1983-08-04 1984-08-03 エリスロマイシンの塩およびそれを有効成分とする抗生−免疫賦活剤
IL72581A IL72581A0 (en) 1983-08-04 1984-08-03 Inosine salts of erythromycin and pharmaceutical compositions comprising them
ES534860A ES534860A0 (es) 1983-08-04 1984-08-03 Procedimiento para la preparacion de sales de eritromicina, o sus esteres, con derivados acidos de la inosina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8322427A IT1206513B (it) 1983-08-04 1983-08-04 Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.

Publications (2)

Publication Number Publication Date
IT8322427A0 IT8322427A0 (it) 1983-08-04
IT1206513B true IT1206513B (it) 1989-04-27

Family

ID=11196162

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8322427A IT1206513B (it) 1983-08-04 1983-08-04 Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.

Country Status (7)

Country Link
EP (1) EP0139891A3 (it)
JP (1) JPS6075431A (it)
AU (1) AU3143184A (it)
DE (1) DE139891T1 (it)
ES (1) ES534860A0 (it)
IT (1) IT1206513B (it)
ZA (1) ZA845997B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
GB2327611B (en) * 1994-10-26 1999-06-02 Novartis Ag Macrolide compositions
EP1459760A1 (en) * 1995-04-21 2004-09-22 University Of South Florida Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof
CN112569251A (zh) * 2020-12-30 2021-03-30 中山大学 次黄嘌呤核苷酸在制备抗感染药物中的应用

Also Published As

Publication number Publication date
ES8505383A1 (es) 1985-06-01
DE139891T1 (de) 1985-12-19
EP0139891A2 (en) 1985-05-08
JPS6075431A (ja) 1985-04-27
ZA845997B (en) 1985-03-27
IT8322427A0 (it) 1983-08-04
EP0139891A3 (en) 1985-06-05
ES534860A0 (es) 1985-06-01
AU3143184A (en) 1985-02-07

Similar Documents

Publication Publication Date Title
FI840662L (fi) Tvaettmedelkompositioner.
DE3486255D1 (de) Pharmazeutische Zusammensetzungen.
DE3483133D1 (de) Pharmazeutische zusammensetzungen.
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI872733L (fi) Farmaceutiska kompositioner.
IT1162879B (it) Composizioni farmaceutiche
FI872313L (fi) Farmaceutiska kompositioner.
FI883673A7 (fi) Farmaceutiska kompositioner.
FI844398A7 (fi) Haimatulehdukseen tehoavia farmaseuttisia koostumuksia.
IT8319958A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
DE3483900D1 (de) Pharmazeutische zusammensetzungen.
FI843110A0 (fi) 4'-halogenantracyklinglykosid.
IT1206513B (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
IT1208432B (it) Composizioni farmaceutiche
IT8249072A0 (it) Composizioni farmaceutiche
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
IT8323632A0 (it) Composizioni farmaceutiche adattivita'antibatterica-immunostimolante.
ES267636Y (es) "lustrador".
ES264864Y (es) "pesacartas".
IT8421627A1 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo
LV5719A4 (lv) Farmaceitiskas kompozicijas
IT1207982B (it) Composizioni farmaceutiche adattivita' antibiotica.
IT8222224A0 (it) Composizione farmaceutica adattivita' antiartritica.